Meda Dymista now available on prescription in UK
Dymista is indicated for the symptomatic treatment of moderate to severe seasonal and perennial allergic rhinitis if monotherapy with either intranasal antihistamine or glucocortocoid is not considered sufficient.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.